Medtronic
MDT
2,123 hedge funds and large institutions have $85.3B invested in Medtronic in 2024 Q4 according to their latest regulatory filings, with 244 funds opening new positions, 790 increasing their positions, 887 reducing their positions, and 153 closing their positions.
59% more first-time investments, than exits
New positions opened: 244 | Existing positions closed: 153
3% more funds holding
Funds holding: 2,063 → 2,123 (+60)
1.19% more ownership
Funds ownership: 82.05% → 83.24% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 31 → 31 (0)
7% less call options, than puts
Call options by funds: $586M | Put options by funds: $632M
10% less capital invested
Capital invested by funds: $94.6B → $85.3B (-$9.36B)
11% less repeat investments, than reductions
Existing positions increased: 790 | Existing positions reduced: 887
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BGC
Beutel, Goodman & Co
Toronto,
Ontario, Canada
|
+$409M |
| 2 |
JP Morgan Chase
New York
|
+$319M |
| 3 |
BlackRock
New York
|
+$252M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$227M |
| 5 |
VanEck Associates
New York
|
+$214M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$520M |
| 2 |
Millennium Management
New York
|
-$404M |
| 3 |
Morgan Stanley
New York
|
-$395M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$313M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$248M |
MDT Hedge Fund Activity: Q4 2024 in Review
2,123 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2024, worth a combined $85.3B — down 9.9% from $94.6B a quarter earlier.
Buyers outnumbered sellers: 244 funds opened new MDT positions and 153 closed out — a net gain of 91 holders — while 790 added to existing stakes and 887 trimmed.
The largest buyer was Beutel, Goodman & Co, opening a new position worth an estimated $409M. The largest seller was Wellington Management Group, cutting an estimated $520M.
- 2,123 institutional investors held Medtronic (MDT) as of Q4 2024, up from 2,063 in Q3 2024.
- Funds reported $85.3B of Medtronic stock for Q4 2024, down 9.9% quarter-over-quarter.
- 244 funds opened new Medtronic positions in Q4 2024 and 153 closed out, a net change of +91 holders.
- The largest Medtronic buyer in Q4 2024 was Beutel, Goodman & Co, an estimated $409M added.
- The largest Medtronic seller in Q4 2024 was Wellington Management Group, an estimated $520M sold.
Based on aggregated 13F filings for Q4 2024.